Business Context and Reporting Period
Company: Processa Pharmaceuticals, Inc. (PCSA)
Filing Type: Form 8-K (Current Report)
Date of Report: January 9, 2023
Reporting Period: Event-based disclosure regarding upcoming investor relations activities.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document serves solely to announce a regulatory disclosure event.
Material Changes
No material changes to financial position or operations are reported in this filing. The document discloses the company's intent to present at the 41st Annual J.P. Morgan Healthcare Conference and the Biotech Showcase.
Guidance, Outlook, and Management Commentary
- Event: Management will present at the 41st Annual J.P. Morgan Healthcare Conference.
- Disclosure Method: The presentation is furnished as Exhibit 99.1 and will be available on the company's website under the "Investors" section.
- Forward-Looking Statements: The company undertakes no duty to update or revise the information contained in the presentation, though it may do so via future reports or press releases.
- Regulation FD: The company notes it routinely uses its website to disclose material non-public information in compliance with Regulation FD.
Investor Verification Checklist
- Verify the content of the investor presentation (Exhibit 99.1) referenced in this filing for specific operational updates or guidance.
- Confirm the date and time of the presentation at the J.P. Morgan Healthcare Conference via the company's investor relations website.
- Review the company's website for any subsequent updates or press releases related to the conference presentation.